Long read sequencing enhances pathogenic and novel variation discovery in patients with rare diseases


The authors used Oxford Nanopore sequencing and a filtration strategy to improve the detection of harmful genetic variants and abnormal methylation profiles in unsolved rare disease cases. They identified pathogenic variants in 10% of individuals with previous negative short-read testing, demonstrating their method’s potential as a rare disease diagnostic tool in the future.

Key points:

  • Short-read sequencing struggles to detect complex structural variants, methylation profiles, and repeat expansions, leaving over 50% of rare disease patients without a diagnosis

  • Sinha, Rabea, and Ramaswamy et al. developed a simplified funnel-down filtration strategy to enhance the identification of deleterious variants and abnormal episignature disease profiles from Oxford Nanopore sequencing data

  • Oxford Nanopore sequencing captured full-length structural changes and epigenetic signatures, allowing for the identification of a novel methylation-based tag for spinal muscular atrophy

  • Pathogenic variants were identified in an additional 5/51 of individuals with suspected rare diseases

Watch Ahmad Abou Tayoun discuss Oxford Nanopore sequencing as a potential diagnostic tool for genetic diseases at London Calling 2023

'Our study illustrates the utility of [Oxford Nanopore sequencing] in clinical genetic testing and the discovery of novel disease variation'

Shruti Sinha, Fatma Rabea, and Sathishkumar Ramaswamy et al.

Sample type: human blood

Kit: Ligation Sequencing Kit

Authors: Shruti Sinha, Fatma Rabea, Sathishkumar Ramaswamy, Ikram Chekroun, Maha El Naofal, Ruchi Jain, Roudha Alfalasi, Nour Halabi, Sawsan Yaslam, Massomeh Sheikh Hassani, Shruti Shenbagam, Alan Taylor, Mohammed Uddin, Mohamed Al Marri, Stefan Du Plessis, Alawi Alsheikh-Ali, Ahmad Abou Tayoun